Cowen and Company’s Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share FSNB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-31,196
Closed -$2K 871
2022
Q3
$2K Buy
+31,196
New +$2.83K ﹤0.01% 611

Other funds holding FSNB.WS

Cowen and Company's FSNB.WS Position: Q4 2022 in Review

Cowen and Company sold out of Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share (FSNB.WS) in Q4 2022, closing a stake of 31,196 shares — an estimated $2K sold.

Cowen and Company first reported a position in FSNB.WS in Q3 2022 and held it in 1 quarter. The position peaked at $2K in Q3 2022. 15 funds tracked by Wall St. Rank hold FSNB.WS as of Q4 2022.

  • Cowen and Company reported no remaining Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • Cowen and Company sold 31,196 Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share shares in Q4 2022, an estimated $2K.
  • Cowen and Company first reported a position in Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share in Q3 2022 and held it in 1 quarter.
  • Cowen and Company's Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position peaked at $2K in Q3 2022.
  • 15 funds tracked by Wall St. Rank held Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share as of Q4 2022.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.